Article 24 Nov 2015 Amgen Uses Agreement To Litigate Patents Under The BPCIA To Rebuff Sham Litigation Claims United States Healthcare
Article 22 Oct 2015 Federal Circuit Declines To Rehear Amgen v. Sandoz En Banc United States Healthcare
Article 21 Oct 2015 Hospira Moves To Dismiss Amgen's BPCIA Claims In Epogen Biosimilars Suit United States Healthcare
Article 12 Oct 2015 FDA Accepts For Review Sandoz's Application For A Biosimilar Of Amgen's Enbrel United States Healthcare
Article 10 Sep 2015 The United States' First-Ever Biosimilar Reaches The Market United States Healthcare
Article 08 Sep 2015 Amgen Panel Denies Emergency Motion For Injunction Pending En Banc Consideration United States Healthcare
Article 28 Aug 2015 Exclusivity Period Of Biologics Remains A Hurdle In Trans-Pacific Partnership Talks United States Healthcare